Navigation Links
Experts discuss use of human stem cells in ape and monkey brains

Covering ship hulls with artificial shark skin could help ships sailing smoothly. The growth of marine organisms such as barnacles on ship hulls is a major cause of increased energy costs in the naval industry. Shark skin offers a structural design that prevents this so called 'bio-fouling'.

Ralph Liedert from the University of Applied Sciences, Bremen, Germany, is presenting his work on the application of artificial shark skin in a new anti-fouling strategy at the Society for Experimental Biology Annual Main Meeting in Barcelona [session A7.66].

Shark skin comprises scales that can flex individually from each other. Liedert produced a synthetic shark skin of elastic silicone, which has a significantly decreased contact surface.

This reduced contact surface makes it harder for barnacles to attach, and reduces fouling by 67%. When applied to the ship hull, this artificial surface enables ships to ´self-clean´, and a speed of 4-5 knots would remove all organisms attached with little adhesion.

Until recently, paints containing a biocide were used to prevent growth on submerged surfaces, but these were banned because of the the toxic effect of the highly toxic and unspecific biocide component on marine life.

As barnacles, mussels and algae cause up to 15% increase in the drag resistence of ships, this research is providing an alternative anti-fouling strategy of great importance.


'"/>

Source:


Page: 1

Related biology news :

1. End of deforestation in view? Experts advance new way to size up global forest resources
2. Scientists discuss improved biopesticides for locust control in West Africa
3. Dalai Lama, top scientists to discuss science & clinical applications of meditation
4. Novel technology detects human DNA mutations
5. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
6. UWs Rosetta software to unlock secrets of many human proteins
7. Genome-wide mouse study yields link to human leukemia
8. Found: Missing sequence of the human Y chromosome
9. Study finds more than one-third of human genome regulated by RNA
10. Molecular machine may lead to new drugs to combat human diseases
11. Sea skate experiment sheds light on human cell transport

Post Your Comments:
(Date:11/4/2009)...ity of North Carolina at Chapel Hill School of Med...sco have developed and experimentally tested a tec... drugs. , The researchers developed a computatio...s of all known drugs are to the naturally occurrin...se targets within the cell. In a study published t...
(Date:11/3/2009)...ore than 25 years, all attempts at culturing pearl...n unsuccessfuluntil now. For the first time, novel...ded (nucleated) and non-beaded cultured pearls fro...s from Florida Atlantic University,s Harbor Branch...o years of research and experimentation, Drs. Hcto...
(Date:11/3/2009)...as 28 percent less likely to become pregnant and h...that earned a Michigan State University professor ..., a researcher in the MSU College of Human Medicin...ductive Biology, focused on data of nearly 50,000 ...Luke,s findings, which also can be applied to wome...
Breaking Biology News(10 mins):Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 55970 1Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 55970 2Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market Notes Frost 26 Sullivan 55968 1Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market Notes Frost 26 Sullivan 55968 2Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market Notes Frost 26 Sullivan 55968 3TrueFACS Announces the Addition of Nora Johnson and Pat Palmer of Medical Billing Advocates of America 55966 1TrueFACS Announces the Addition of Nora Johnson and Pat Palmer of Medical Billing Advocates of America 55966 2
...discovered that human embryonic stem cell lines ac...me. , The findings do not limit the utility of th...ure clinical applications, the researchers say, bu...em cell lines for genetic changes and to study how... researchers, work is described in the Sept. 4 onl...
...s in India has risen in response to a 20-fold drop...ording to an article in the Nov. 15 issue of Clini... introduction of generic drugs into the country ha...of the cheaper cost, the article states. , Many of...g in India have been unable to obtain treatment du...
... people with compromised immune systems may be fea...s, who demonstrated their approach could protect a...same population of immune cells that HIV destroys ...ren,s Hospital of Pittsburgh researchers, working ...ity of Pittsburgh and Louisiana State University, ...
Other Biology News:Embryonic stem cells accrue genetic changes 2Embryonic stem cells accrue genetic changes 3Embryonic stem cells accrue genetic changes 4HIV mortality in India drops with introduction of generic antiretroviral therapy 2New vaccine platform may fight infections with causes from influenza to bioterrorism 2New vaccine platform may fight infections with causes from influenza to bioterrorism 3
(Date:11/7/2009)...,, CAMBRIDGE, Mass., Nov. 7, Re...ochemistry scored top marks this evening, as Tim K...Song and Quan (Jack) Chen of Audubon, PA received ...e 2009 Siemens Competition in Math, Science & ...ce competition. ,, ( http://www.newscom.com/cg...
(Date:11/6/2009)...,, QUINCY, Mass., Nov. 6 Myrian...biotech developer and manufacturer of renewable b...preferred technology provider Uhde GmbH, one of th... "Uhde"), announced an alliance for the engineerin...,s biobased Succinic Acid plants based on renewabl...
(Date:11/6/2009)...,, CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onc...lytics" or the "Company") today announced updated ...SIN(R) in patients with sarcomas metastatic to the...Connective Tissue Oncology Society Meeting held in...he poster presentation, entitled "A Phase II Study...
(Date:11/5/2009)...,, GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstC...ced its financial results for the third quarter en... of $3.6 million ($0.04 per share) for the three m...oss of $6.8 million ($0.08 per share) in the compa...eptember 30, 2009, GenVec,s net loss was $14.1 mil...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... 17 Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ..., today announced that its lead product candidate,...uct designation for the treatment of,small cell lu...designation,is based on a recommendation from the ...the European Medicines Agency (EMEA). Picoplatin ...
...lt announced today that,the Henry C. Witelson Ocul...ealth Centre has purchased a Personal Archive bios... in Montreal, Quebec. GenVault technology will be... in determining the mechanisms underlying eye canc...for developing new approaches for,treatment. These...
...ea Pharmaceuticals,Inc. announced today that BC De...diagnostic test, is now available from Panacea Lab...at should facilitate the identification,of recurre...ncer. Panacea,Laboratories, a division of Panacea ...aboratory Improvement Amendments of 1988 (CLIA). T...
Other Biology Technology:Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 2Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 3Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer 4McGill University Purchases GenVault's Personal Archive System to Manage Rare Cancer Samples 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 2Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 3Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer 4
Immulon 4 HBX 1x12 Strip from Thermo Scientific
Perfusion Pressure Kit - 8 channel from AutoMate Scientific, Inc
Nar I from Promega
Chicken Anti-UCK2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: